| Trial ID: | L5204 |
| Source ID: | NCT00707590
|
| Associated Drug: |
Bms-767778 Or Placebo
|
| Title: |
Safety Study to Evaluate BMS-767778 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus (T2DM)
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: BMS-767778 or Placebo
|
| Outcome Measures: |
Primary: AEs, vital signs, ECG and clinical laboratory test results, throughout the study | Secondary: Single and multiple dose (14 days) PK, throughout the study|DPP-4 inhibition and incretin response, throughout the study
|
| Sponsor/Collaborators: |
Sponsor: Bristol-Myers Squibb
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
120
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2008-08
|
| Completion Date: |
2008-11
|
| Results First Posted: |
|
| Last Update Posted: |
2009-02-10
|
| Locations: |
Local Institution, Quebec, G1P 0A2, Canada
|
| URL: |
https://clinicaltrials.gov/show/NCT00707590
|
